Sep 20, 2026, 00:50
A Shared Platelet Factor 4–Targeted Immune Mechanism in Adenovirus Infection – NEJM
The New England Journal of Medicine (NEJM) shared a post on X about a recent article by Christian Irsara et al., adding:
“Virus-induced immune thrombocytopenia and thrombosis after HAdV-B3 infection supports a shared platelet factor 4–targeted immune mechanism linking natural adenovirus infection and adenoviral vector–associated disease.”
Title: Human Adenovirus B3–Induced Immune Thrombocytopenia and Thrombosis
Authors: Christian Irsara, Habib Benainouna, Jing Jing Wang, Andrea Griesmacher, Christoph Winkler, Lorin Loacker, Markus Anliker, Xiaoyan Wang, Alex Moser, Thomas Müller, Werner Streif, Andreas Greinacher, Thomas Thiele, Wibke Bayer, Linda Schönborn

Other posts featuring NEJM on Hemostasis Today.
adenovirus
Alex Moser
Andrea Griesmacher
Andreas Greinacher
Blood
Christian Irsara
Christoph Winkler
Habib Benainouna
HAdV-B3
Health
Hematology
Hemostasis
Hemostasis News
Hemostasis Today
Immune thrombocytopenia
ITP
Jing Jing Wang
Linda Schönborn
Lorin Loacker
Markus Anliker
Medicine
NEJM
The New England Journal of Medicine
Thomas Müller
Thomas Thiele
thrombocytopenia
thrombosis
Virus-induced immune thrombocytopenia
Werner Streif
Wibke Bayer
Xiaoyan Wang
-
Sep 20, 2026, 00:46Julia R. Coleman: Platelet Biology and Sex Differences in the Plasma Milieu at AAST 2026
-
Sep 19, 2026, 18:03Manisha Madkaikar: Clinical, Hematological, and Molecular Features of Sickle β-Thalassemia
-
Sep 19, 2026, 17:24Jan Shawqi Goran: Understanding Beta Thalassemia Before Marriage Testing
-
Sep 19, 2026, 14:17Abdul Mannan: What Exactly Is a Platelet?
-
Sep 19, 2026, 13:39Keisuke Goda: Decoding Platelet Phenotypes in COVID-19 With Optofluidic Imaging
-
Sep 19, 2026, 13:30Targeted Thrombolysis Beyond tPA
-
Sep 19, 2026, 13:21Paul Armstrong: From Summer Studentship to Young Researcher
-
Sep 19, 2026, 13:06Rabiya Masood: Breaking the Cycle of Thalassemia Through Screening
-
Sep 19, 2026, 10:52Consuela A. Albright: The Critical Role of Black Blood Donors in Sickle Cell Treatment